197 related articles for article (PubMed ID: 35379876)
1. A mouse model with widespread expression of the C9orf72-linked glycine-arginine dipeptide displays non-lethal ALS/FTD-like phenotypes.
Verdone BM; Cicardi ME; Wen X; Sriramoji S; Russell K; Markandaiah SS; Jensen BK; Krishnamurthy K; Haeusler AR; Pasinelli P; Trotti D
Sci Rep; 2022 Apr; 12(1):5644. PubMed ID: 35379876
[TBL] [Abstract][Full Text] [Related]
2. DDX3X overexpression decreases dipeptide repeat proteins in a mouse model of C9ORF72-ALS/FTD.
Fu X; Zhang Z; Hayes LR; Wright N; Asbury J; Li S; Ye Y; Sun S
Exp Neurol; 2024 Jun; 376():114768. PubMed ID: 38556190
[TBL] [Abstract][Full Text] [Related]
3. Inflammasome-Mediated Neuronal-Microglial Crosstalk: a Therapeutic Substrate for the Familial C9orf72 Variant of Frontotemporal Dementia/Amyotrophic Lateral Sclerosis.
Trageser KJ; Yang EJ; Smith C; Iban-Arias R; Oguchi T; Sebastian-Valverde M; Iqbal UH; Wu H; Estill M; Al Rahim M; Raval U; Herman FJ; Zhang YJ; Petrucelli L; Pasinetti GM
Mol Neurobiol; 2023 Jul; 60(7):4004-4016. PubMed ID: 37010807
[TBL] [Abstract][Full Text] [Related]
4. Senataxin helicase, the causal gene defect in ALS4, is a significant modifier of C9orf72 ALS G4C2 and arginine-containing dipeptide repeat toxicity.
Bennett CL; Dastidar S; Arnold FJ; McKinstry SU; Stockford C; Freibaum BD; Sopher BL; Wu M; Seidner G; Joiner W; Taylor JP; West RJH; La Spada AR
Acta Neuropathol Commun; 2023 Oct; 11(1):164. PubMed ID: 37845749
[TBL] [Abstract][Full Text] [Related]
5. C9orf72-associated dipeptide protein repeats form A11-positive oligomers in amyotrophic lateral sclerosis and frontotemporal dementia.
Bhatt N; Puangmalai N; Sengupta U; Jerez C; Kidd M; Gandhi S; Kayed R
J Biol Chem; 2024 Feb; 300(2):105628. PubMed ID: 38295729
[TBL] [Abstract][Full Text] [Related]
6. Reactivation of nonsense-mediated mRNA decay protects against C9orf72 dipeptide-repeat neurotoxicity.
Xu W; Bao P; Jiang X; Wang H; Qin M; Wang R; Wang T; Yang Y; Lorenzini I; Liao L; Sattler R; Xu J
Brain; 2019 May; 142(5):1349-1364. PubMed ID: 30938419
[TBL] [Abstract][Full Text] [Related]
7. Evidence that C9ORF72 Dipeptide Repeat Proteins Associate with U2 snRNP to Cause Mis-splicing in ALS/FTD Patients.
Yin S; Lopez-Gonzalez R; Kunz RC; Gangopadhyay J; Borufka C; Gygi SP; Gao FB; Reed R
Cell Rep; 2017 Jun; 19(11):2244-2256. PubMed ID: 28614712
[TBL] [Abstract][Full Text] [Related]
8. Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy.
Chew J; Cook C; Gendron TF; Jansen-West K; Del Rosso G; Daughrity LM; Castanedes-Casey M; Kurti A; Stankowski JN; Disney MD; Rothstein JD; Dickson DW; Fryer JD; Zhang YJ; Petrucelli L
Mol Neurodegener; 2019 Feb; 14(1):9. PubMed ID: 30767771
[TBL] [Abstract][Full Text] [Related]
9. The mTORC2/AKT/VCP axis is associated with quality control of the stalled translation of poly(GR) dipeptide repeats in C9-ALS/FTD.
Li Y; Geng J; Rimal S; Wang H; Liu X; Lu B; Li S
J Biol Chem; 2023 Mar; 299(3):102995. PubMed ID: 36764521
[TBL] [Abstract][Full Text] [Related]
10. C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels.
Beckers J; Tharkeshwar AK; Van Damme P
Autophagy; 2021 Nov; 17(11):3306-3322. PubMed ID: 33632058
[TBL] [Abstract][Full Text] [Related]
11. Proline-arginine poly-dipeptide encoded by the C9orf72 repeat expansion inhibits adenosine deaminase acting on RNA.
Suzuki H; Matsuoka M
J Neurochem; 2021 Aug; 158(3):753-765. PubMed ID: 34081786
[TBL] [Abstract][Full Text] [Related]
12. Repeated repeat problems: Combinatorial effect of C9orf72-derived dipeptide repeat proteins.
Darling AL; Breydo L; Rivas EG; Gebru NT; Zheng D; Baker JD; Blair LJ; Dickey CA; Koren J; Uversky VN
Int J Biol Macromol; 2019 Apr; 127():136-145. PubMed ID: 30639592
[TBL] [Abstract][Full Text] [Related]
13. Translation of dipeptide repeat proteins in
Sonobe Y; Lee S; Krishnan G; Gu Y; Kwon DY; Gao FB; Roos RP; Kratsios P
Elife; 2023 Sep; 12():. PubMed ID: 37675986
[TBL] [Abstract][Full Text] [Related]
14. Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features.
Shaw MP; Higginbottom A; McGown A; Castelli LM; James E; Hautbergue GM; Shaw PJ; Ramesh TM
Acta Neuropathol Commun; 2018 Nov; 6(1):125. PubMed ID: 30454072
[TBL] [Abstract][Full Text] [Related]
15. C9orf72 ALS/FTD dipeptide repeat protein levels are reduced by small molecules that inhibit PKA or enhance protein degradation.
Licata NV; Cristofani R; Salomonsson S; Wilson KM; Kempthorne L; Vaizoglu D; D'Agostino VG; Pollini D; Loffredo R; Pancher M; Adami V; Bellosta P; Ratti A; Viero G; Quattrone A; Isaacs AM; Poletti A; Provenzani A
EMBO J; 2022 Jan; 41(1):e105026. PubMed ID: 34791698
[TBL] [Abstract][Full Text] [Related]
16. Poly(GR) and poly(GA) in cerebrospinal fluid as potential biomarkers for C9ORF72-ALS/FTD.
Krishnan G; Raitcheva D; Bartlett D; Prudencio M; McKenna-Yasek DM; Douthwright C; Oskarsson BE; Ladha S; King OD; Barmada SJ; Miller TM; Bowser R; Watts JK; Petrucelli L; Brown RH; Kankel MW; Gao FB
Nat Commun; 2022 May; 13(1):2799. PubMed ID: 35589711
[TBL] [Abstract][Full Text] [Related]
17. Poly(GR) impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis.
Zhang YJ; Gendron TF; Ebbert MTW; O'Raw AD; Yue M; Jansen-West K; Zhang X; Prudencio M; Chew J; Cook CN; Daughrity LM; Tong J; Song Y; Pickles SR; Castanedes-Casey M; Kurti A; Rademakers R; Oskarsson B; Dickson DW; Hu W; Gitler AD; Fryer JD; Petrucelli L
Nat Med; 2018 Aug; 24(8):1136-1142. PubMed ID: 29942091
[TBL] [Abstract][Full Text] [Related]
18. Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutant amyotrophic lateral sclerosis and are unlikely to cause their degeneration.
Gomez-Deza J; Lee YB; Troakes C; Nolan M; Al-Sarraj S; Gallo JM; Shaw CE
Acta Neuropathol Commun; 2015 Jun; 3():38. PubMed ID: 26108573
[TBL] [Abstract][Full Text] [Related]
19. Circadian sleep/wake-associated cells show dipeptide repeat protein aggregates in C9orf72-related ALS and FTLD cases.
Dedeene L; Van Schoor E; Vandenberghe R; Van Damme P; Poesen K; Thal DR
Acta Neuropathol Commun; 2019 Dec; 7(1):189. PubMed ID: 31791419
[TBL] [Abstract][Full Text] [Related]
20. UBQLN2-HSP70 axis reduces poly-Gly-Ala aggregates and alleviates behavioral defects in the C9ORF72 animal model.
Zhang K; Wang A; Zhong K; Qi S; Wei C; Shu X; Tu WY; Xu W; Xia C; Xiao Y; Chen A; Bai L; Zhang J; Luo B; Wang W; Shen C
Neuron; 2021 Jun; 109(12):1949-1962.e6. PubMed ID: 33991504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
